Genome-wide DNA methylation profiles in hepatocellular carcinoma
Open Access
- 11 January 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 55 (6), 1799-1808
- https://doi.org/10.1002/hep.25569
Abstract
Alterations in DNA methylation frequently occur in hepatocellular cancer (HCC). We have previously demonstrated that hypermethylation in candidate genes can be detected in plasma DNA before HCC diagnosis. To identify, with a genome‐wide approach, additional genes hypermethylated in HCC that could be used for more accurate analysis of plasma DNA for early diagnosis, we analyzed tumor and adjacent nontumor tissues from 62 Taiwanese HCC cases using Illumina methylation arrays (Illumina, Inc., San Diego, CA) that screen 26,486 autosomal CpG sites. After Bonferroni adjustment, a total of 2,324 CpG sites significantly differed in methylation level, with 684 CpG sites significantly hypermethylated and 1,640 hypomethylated in tumor, compared to nontumor tissues. Array data were validated with pyrosequencing in a subset of five of these genes; correlation coefficients ranged from 0.92 to 0.97. Analysis of plasma DNA from 38 cases demonstrated that 37%‐63% of cases had detectable hypermethylated DNA (≥5% methylation) for these five genes individually. At least one of these genes was hypermethylated in 87% of the cases, suggesting that measurement of DNA methylation in plasma samples is feasible. Conclusion: The panel of methylated genes indentified in the current study will be further tested in a large cohort of prospectively collected samples to determine their utility as early biomarkers of HCC. (HEPATOLOGY 2012;55:1799–1810)This publication has 37 references indexed in Scilit:
- Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomasCarcinogenesis: Integrative Cancer Research, 2008
- Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast ChinaMutation research. Reviews in mutation research, 2008
- Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liverInternational Journal of Cancer, 2008
- Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinomaInternational Journal of Cancer, 2007
- Silencing of glutathione S-transferaseP1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinomaCancer Letters, 2005
- High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinomaLiver International, 2005
- p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinomaGastroenterology, 1999
- p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.1997
- Inactivation of p16INK4 in hepatocellular carcinomaHepatology, 1996
- Alfatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissueCarcinogenesis: Integrative Cancer Research, 1991